Target Name: SECISBP2
NCBI ID: G79048
Review Report on SECISBP2 Target / Biomarker Content of Review Report on SECISBP2 Target / Biomarker
SECISBP2
Other Name(s): SECIS-binding protein 2 | SECISBP2 variant 1 | Selenocysteine insertion sequence-binding protein 2 | DKFZp434B216 | SBP2 | Selenocysteine insertion sequence-binding protein 2 (isoform 1) | SEBP2_HUMAN | RP11-89K14.1 | Sec insertion sequence-binding protein 2 | MGC3156 | SECIS binding protein 2 | SECIS binding protein 2, transcript variant 1 | Selenocysteine insertion sequence binding protein 2 | THMA1

SECISBP2: A Potential Drug Target and Biomarker

Introduction

SECISBP2 (SECIS-binding protein 2) is a protein that is expressed in various tissues and cells of the human body. It is a member of the SECISBP family, which includes proteins that play a critical role in the regulation of cell signaling pathways. Several studies have identified SECISBP2 as a potential drug target and biomarker, and further research is needed to determine its full potential.

The ProteinsecisBP2 (SECIS-binding protein 2)

SECISBP2 is a 120-kDa protein that is expressed in various tissues and cells of the human body. It is characterized by a N-terminal 伪-helix, a C-terminal conserved 尾-sheet, and a C-terminal long amine group acid sequence. SECISBP2 plays an important role in cell signaling pathways and is one of the key players in multiple signaling pathways.

Biological functions of SECISBP2

SECISBP2 plays an important role in a variety of physiological processes. SECISBP2 plays a crucial role in cell proliferation and apoptosis. Studies have shown that SECISBP2 regulates the formation and disappearance of spindles during the cell cycle and plays an important role in the assembly and disassembly of spindle microtubules. In addition, SECISBP2 is also involved in the regulation of apoptosis and is one of the key players in the apoptosis signaling pathway.

Pharmacological significance of SECISBP2

SECISBP2 is a potential drug target. Studies have shown that SECISBP2 is overexpressed in a variety of tumor cells and plays an important role in tumor growth and metastasis. In addition, SECISBP2 is also closely related to the occurrence and development of various diseases, such as neurodegenerative diseases, diabetes and obesity. Therefore, SECISBP2 is considered a potential drug target.

Detection of SECISBP2

Currently, there are two main methods for detecting SECISBP2: Western blot and immunohistochemistry. Western blot is a commonly used detection method that can detect the protein expression level of SECISBP2. Immunohistochemistry is a method to directly observe protein expression in cells, and can detect the expression of SECISBP2 in cells.

Biological activity of SECISBP2

SECISBP2 plays an important role in a variety of physiological processes and has a variety of biological activities. Studies have shown that SECISBP2 can regulate cell proliferation and apoptosis and participate in the regulation of cell signaling pathways. In addition, SECISBP2 can also participate in cell adhesion, migration and tumor cell invasion.

Conclusion

SECISBP2 is a potential drug target and an important biomarker. further research is needed to determine its full potential as a drug target and biomarker.

Protein Name: SECIS Binding Protein 2

Functions: Binds to the SECIS element in the 3'-UTR of some mRNAs encoding selenoproteins. Binding is stimulated by SELB

The "SECISBP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SECISBP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SECISBP2L | SECTM1 | Segment polarity protein dishevelled homolog | SEH1L | SEL1L | SEL1L2 | SEL1L3 | SELE | SELENBP1 | SELENOF | SELENOH | SELENOI | SELENOK | SELENOKP1 | SELENOM | SELENON | SELENOO | SELENOOLP | SELENOP | Selenoprotein | SELENOS | SELENOT | SELENOV | SELENOW | SELL | SELP | SELPLG | SEM1 | SEM1P1 | SEMA3A | SEMA3B | SEMA3B-AS1 | SEMA3C | SEMA3D | SEMA3E | SEMA3F | SEMA3G | SEMA4A | SEMA4B | SEMA4C | SEMA4D | SEMA4F | SEMA4G | SEMA5A | SEMA5A-AS1 | SEMA5B | SEMA6A | SEMA6A-AS1 | SEMA6A-AS2 | SEMA6B | SEMA6C | SEMA6D | SEMA7A | Semenogelin | SEMG1 | SEMG2 | SENCR | SENP1 | SENP2 | SENP3 | SENP3-associated complex | SENP3-EIF4A1 | SENP5 | SENP6 | SENP7 | SENP8 | SEPHS1 | SEPHS1P4 | SEPHS1P6 | SEPHS2 | SEPSECS | SEPSECS-AS1 | SEPT5-GP1BB | SEPTIN1 | SEPTIN10 | SEPTIN11 | SEPTIN12 | SEPTIN14 | SEPTIN2 | SEPTIN3 | SEPTIN4 | SEPTIN4-AS1 | SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63